NIH-funded research Career grant

Microglial diversity and cognitive resilience in aging and Alzheimer's disease

Official title: Role of Microglial Heterogeneity on Cognitive Resilience in Aging and Alzheimer’s Disease

Funded at Mayo Clinic Rochester · NIH-11336377 · Data updated 2026-11-12

A physician-scientist at Mayo Clinic is pursuing a five-year career development plan to understand how different microglia behave in aging and Alzheimer’s, aiming to improve brain health and resilience.

More s Disease research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2026
Award (this year)$155,520
NIH project number5K08AG081460-03
Project IDNIH-11336377 on NIH RePORTER

Who could benefit from this research

Could help

Individuals at risk for or diagnosed with Alzheimer’s disease or Alzheimer’s-type dementia, and aging adults at risk for cognitive decline.

Less likely to help

Some participants may not experience direct benefits if they do not have the disease or biomarkers studied, or if imaging findings do not translate to clinical outcomes.

What this research studies

This project supports Dr. Aivi Nguyen as she develops skills in combining brain biomarkers, neuropsychiatric data, and postmortem brain analysis with advanced imaging of microglia in mouse models. The work blends antemortem biomarker data with detailed pathology to explore how microglial differences relate to cognitive resilience in aging and Alzheimer’s disease. Protected time will be used to gain expertise in two-photon in vivo imaging and translational neuropathology under senior mentors, with a focus on translating findings to human disease. The goal is to build a foundation for independent, patient-focused research that could inform future therapies for aging-related cognitive decline and Alzheimer’s pathology.

Why it matters

Potential benefit: If successful, the project could reveal microglial features linked to better cognitive resilience, guiding new approaches to preserve brain health in aging and Alzheimer's disease.

How similar studies have gone: Previous studies show microglial involvement in aging and neurodegeneration; this proposal builds on that knowledge with a translational, human-focused approach.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Nguyen, Aivi Thanh — Mayo Clinic Rochester
  • Study coordinator: Nguyen, Aivi Thanh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.